Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure (TEAM-HF)

This study has been terminated.
(Poor enrollment)
Sponsor:
Collaborator:
Daxor Corporation
Information provided by (Responsible Party):
Stuart Katz, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01001312
First received: October 22, 2009
Last updated: October 8, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)